Sunmax Biotechnology Co Ltd (4728) — Cash Flow Quality Index
Sunmax Biotechnology Co Ltd (4728) has a Cash Flow Quality Index of 0.85x as of September 2025. Operating cash flow of NT$160.84 Million is below net income of NT$189.68 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore how well can Sunmax Biotechnology Co Ltd service its debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Sunmax Biotechnology Co Ltd Cash Flow Quality Index (2016–2024)
Historical Cash Flow Quality Index for Sunmax Biotechnology Co Ltd across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Sunmax Biotechnology Co Ltd cash flow conversion.
Annual Cash Flow Quality Index for Sunmax Biotechnology Co Ltd (2016–2024)
Year-by-year earnings quality comparison for Sunmax Biotechnology Co Ltd.
| Year | Quality Index | Operating CF (TWD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.58x | NT$397.37 Million | NT$679.40 Million | ▼ -37.3% |
| 2023 | 0.93x | NT$848.56 Million | NT$909.39 Million | ▲ +45.2% |
| 2022 | 0.64x | NT$342.97 Million | NT$533.83 Million | ▼ -5.6% |
| 2021 | 0.68x | NT$243.28 Million | NT$357.49 Million | ▼ -40.6% |
| 2020 | 1.15x | NT$386.97 Million | NT$337.76 Million | ▼ -60.2% |
| 2019 | 2.88x | NT$289.51 Million | NT$100.45 Million | ▲ +113.4% |
| 2018 | 1.35x | NT$100.83 Million | NT$74.66 Million | ▼ -39.8% |
| 2017 | 2.24x | NT$37.09 Million | NT$16.54 Million | ▼ -76.4% |
| 2016 | 9.51x | NT$16.58 Million | NT$1.74 Million | — |